These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24641114)

  • 1. Cutaneous siderosis after intramuscular iron injections: a case report.
    Ozlu E; Karadag AS; Bilgili SG; Bayram I
    Cutan Ocul Toxicol; 2014 Dec; 33(4):348-50. PubMed ID: 24641114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Localized cutaneous siderosis following intramuscular iron injections].
    Bork K
    Hautarzt; 1984 Nov; 35(11):598-9. PubMed ID: 6519991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous siderosis secondary to intramuscular iron dextran treated with 755 nm Q-switched alexandrite laser: A case report.
    Lloyd AA; Graves MS; Ross EV
    Lasers Surg Med; 2015 Jul; 47(5):386-7. PubMed ID: 25994768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Iatrogenic Cutaneous Siderosis with Pigment Lasers: A Retrospective Study in 15 Consecutive Patients.
    Heidemeyer K; Feldmeyer L; Raeber I; Dietrich N; Cazzaniga S; Yawalkar N; Seyed Jafari SM; Borradori L; Adatto M
    Acta Derm Venereol; 2020 May; 100(10):adv00148. PubMed ID: 32399574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
    Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
    An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary siderosis due to iron oxide in workers: an inert dust?].
    Algranti E; Morrone LC; Morrone N; Furlaneto JA; Garcia RC; Cardoso RS
    Rev Paul Med; 1985; 103(5):259-64. PubMed ID: 3832318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferumoxytol: an intravenous iron, riskier than iron sucrose.
    Prescrire Int; 2013 Sep; 22(141):206. PubMed ID: 24171212
    [No Abstract]   [Full Text] [Related]  

  • 10. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral iron.
    Nurs Times; 2006 Jun 27-Jul 3; 102(26):40. PubMed ID: 16845816
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anaphylactic reaction after Fe-injection].
    Fiechter R; Batschwaroff M; Conen D
    Praxis (Bern 1994); 2005 Feb; 94(6):209-12. PubMed ID: 15754533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of iron deficiency.
    Callender ST
    Clin Haematol; 1982 Jun; 11(2):327-38. PubMed ID: 7042154
    [No Abstract]   [Full Text] [Related]  

  • 14. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
    Befrits R; Wikman O; Blomquist L; Hjortswang H; Hammarlund P; Bajor A; Klintman D; Blom H
    Scand J Gastroenterol; 2013 Sep; 48(9):1027-32. PubMed ID: 23889159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic and clinical evaluation of iron poly (sorbitol-gluconic acid) complex.
    Campbell BC; Lawrence JR; Sumner DJ; Kelman A; Smith A; Elliott HL; Goldberg A
    Pharmatherapeutica; 1980; 2(7):475-80. PubMed ID: 7208542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gluteal pigmentation after intramuscular iron injections.
    Doutre MS; Beylot-Barry M; Beylot C; Vergier B; Surleve-Bazeille JE
    Dermatology; 1996; 192(2):187-8. PubMed ID: 8829512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Newly diagnosed iron deficiency anemia in a premenopausal woman].
    Todd T; Caroe T
    Praxis (Bern 1994); 2008 Jun; 97(13):735-6. PubMed ID: 18770926
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron medication-induced gastric mucosal injury.
    Zhang X; Ouyang J; Wieczorek R; DeSoto F
    Pathol Res Pract; 2009; 205(8):579-81. PubMed ID: 19232839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison trial of iron succinylprotein complex or iron gluconate complex in the treatment of iron deficiency anemia.
    Pedrazzoli P; Scotti A; Farina D
    Clin Ther; 1988; 10(4):414-20. PubMed ID: 3079009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex.
    Byun HH; Rodman SG; Chung KE
    J Nucl Med; 1976 May; 17(5):374-5. PubMed ID: 1262940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.